High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

被引：0
|
作者：
Cécile Goujard
Mayeule Legrand
Xavière Panhard
Bertrand Diquet
Xavier Duval
Gilles Peytavin
Isabelle Vincent
Christine Katlama
Catherine Leport
Bénédicte Bonnet
Dominique Salmon-Céron
France Mentré
Anne-Marie Taburet
机构：
[1] Bicêtre University Hospital,Internal Medicine Unit
[2] AP-HP,Clinical Pharmacology Laboratory
[3] Pitié-Salpêtrière University Hospital,Department of Epidemiology, Biostatistics and Clinical Research
[4] AP-HP,Infectious and Tropical Diseases Unit
[5] Bichat University Hospital,Pharmacy
[6] AP-HP,Clinical Pharmacy
[7] Bichat University Hospital,Infectious and Tropical Diseases Unit
[8] AP-HP,Internal Medicine Unit, Hotel
[9] Bichat University Hospital,Dieu
[10] AP-HP,Internal Medicine — Infectious and Tropical Diseases Department
[11] Bicêtre University Hospital,Service de Médecine Interne
[12] AP-HP,undefined
[13] Pitié-Salpêtrière University Hospital,undefined
[14] AP-HP,undefined
[15] University Hospital,undefined
[16] Cochin University Hospital,undefined
[17] AP-HP,undefined
[18] Hôpital Bicêtre,undefined
来源：
Clinical Pharmacokinetics | 2005年 / 44卷
关键词：
Sustained Virological Response; Ritonavir; Therapeutic Drug Monitoring; Indinavir; Nelfinavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1267 / 1278
页数：11
相关论文
共 50 条
  • [1] High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy
    Goujard, U
    Legrand, M
    Panhard, X
    Diquet, B
    Duval, X
    Peytavin, G
    Vincent, I
    Katlama, C
    Leport, C
    Bonnet, B
    Salmon-Céron, D
    Mentré, F
    Taburet, AM
    CLINICAL PHARMACOKINETICS, 2005, 44 (12) : 1267 - 1278
  • [2] Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir
    Walmsley, SL
    Becker, MI
    Zhang, M
    Humar, A
    Harrigan, PR
    ANTIVIRAL THERAPY, 2001, 6 (01) : 47 - 54
  • [3] Predictive factors of the virological response in a cohort of 330 HIV-infected patients undergoing highly active antiretroviral therapy
    Ladisa, N
    Perulli, LM
    Maggi, P
    Lopalco, PL
    Angarano, G
    Pastore, G
    XIII CONVEGNO NAZIONALE AIDS E SINDROMI CORRELATE, 2000, : 37 - 42
  • [4] Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients
    Bonfanti, P
    Capetti, A
    Di Mattei, P
    Niero, F
    Rizzardini, G
    AIDS, 1998, 12 (09) : 1111 - 1111
  • [5] Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients
    Duval, X
    Peytavin, G
    Albert, I
    Bénoliel, S
    Ecobichon, JL
    Brun-Vézinet, F
    Mentré, F
    Leport, C
    Vildé, JL
    HIV MEDICINE, 2004, 5 (04) : 307 - 313
  • [6] The effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Jensen-Fangel, S
    DANISH MEDICAL BULLETIN, 2004, 51 (04) : 371 - 392
  • [7] PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Tisch, Stephen
    Brew, Bruce
    NEUROLOGY, 2009, 73 (05) : 401 - 403
  • [8] Parkinsonism in HIV-infected patients on highly active antiretroviral therapy
    Tisch, S.
    Brew, B. J.
    MOVEMENT DISORDERS, 2009, 24 : S425 - S425
  • [9] Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response
    Atreya, Auras R.
    Arora, Sonali
    Gadiraju, Vijay T.
    Martagon-Villamil, Jose
    Skiest, Daniel J.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (05) : 383 - 386
  • [10] Trough plasma levels of nelfinavir or indinavir correlate with virological response to HAART in HIV infected patients
    Duval, X
    Peytavin, G
    Albert, I
    Ecobichon, JL
    Le Miong, V
    Longuet, P
    Adam, O
    Brun-Vezinet, F
    Mentre, F
    Leport, C
    Vilde, JL
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 270 - 270
12345